Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidant Therapy in Septic Shock
NCT03557229Phase 3Unknown
- Sponsor
- Centro Médico ABC
- Start
- Jul 2018
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melatonin, ascorbic acid, alpha-tocopherol, acetylcysteine in septic shock, sponsored by Centro Médico ABC. Status: unknown.
02
Drugs
melatoninascorbic acidalpha-tocopherolacetylcysteine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03557229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03557229.